Matthew Callstrom, President and CEO of Mayo Clinic, shared on LinkedIn:
“I am deeply honored to have been selected to serve as the next president and CEO of Mayo Clinic. For more than 25 years, Mayo Clinic has been my professional home, drawn to an organization where people come together around our primary value of putting the needs of the patient first.
Since joining, I’ve had the privilege of caring for patients, advancing research and innovation, and working alongside remarkable colleagues across our practice. My leadership roles in strategy, AI, and development have given me an even broader appreciation for what makes Mayo Clinic so special, and for the responsibility we have to ensure it remains so for generations to come.
I am grateful to Gianrico Farrugia, for his leadership and for the tremendous transformation Mayo Clinic has made during his tenure. It is an honor to build on this legacy as we continue to work toward transformational change in healthcare to better serve patients everywhere.
Most of all, I look forward to serving alongside colleagues whose expertise, curiosity, and commitment to our patients inspire me every day.
Gianrico Farrugia, Former President and CEO of Mayo Clinic, shared Matthew Callstrom’s post, adding:
“Matthew Callstrom knows Mayo Clinic deeply, understands where healthcare is headed and has the vision and experience to build on the progress we have made.
Congratulations to my colleague and friend, and I look forward to all that you and our remarkable, Category-of-One staff at Mayo will accomplish together.”
About Dr. Matthew Callstrom
Dr. Matthew Callstrom is an internationally recognized interventional radiologist, physician-scientist, and executive leader at Mayo Clinic. His clinical and research work focuses on image-guided cancer therapies, particularly minimally invasive tumor ablation techniques, including cryoablation and radiofrequency ablation, for cancers of the liver, kidney, lung, bone, and soft tissue.
He has led numerous clinical trials and contributed to advancements in image-guided interventions, image-fusion technologies, and the integration of artificial intelligence into diagnostic imaging and cancer care. His research has also explored the relationship between tumor ablation and anti-tumor immune responses.
A founding member and past president of the Society of Interventional Oncology, Dr. Callstrom has authored more than 180 peer-reviewed publications, holds several medical technology patents, and co-edited Image-Guided Interventions in Oncology. He has received the Mayo Clinic Distinguished Clinical Award and was recognized among the World’s Top 2% Researchers by Stanford University and Elsevier.
Other articles about Mayo Clinic on OncoDaily.